GH Research PLC (NASDAQ:GHRS – Get Free Report) saw a large increase in short interest in September. As of September 30th, there was short interest totalling 1,600,000 shares, an increase of 6.0% from the September 15th total of 1,510,000 shares. Based on an average daily volume of 39,800 shares, the short-interest ratio is currently 40.2 days. Currently, 5.3% of the shares of the stock are sold short.
GH Research Stock Up 9.0 %
Shares of GHRS stock traded up $0.64 during trading hours on Wednesday, reaching $7.74. 101,114 shares of the stock traded hands, compared to its average volume of 81,278. The firm has a market capitalization of $402.70 million, a PE ratio of -12.48 and a beta of 0.79. GH Research has a 1-year low of $5.05 and a 1-year high of $14.99. The business has a fifty day moving average price of $8.61 and a 200 day moving average price of $10.78.
GH Research (NASDAQ:GHRS – Get Free Report) last announced its earnings results on Tuesday, September 3rd. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.23) by $0.03. Research analysts expect that GH Research will post -0.89 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several research firms recently commented on GHRS. HC Wainwright reissued a “buy” rating and set a $40.00 target price on shares of GH Research in a research note on Thursday, September 5th. JMP Securities reiterated a “market outperform” rating and set a $39.00 price objective on shares of GH Research in a research report on Wednesday, September 4th.
View Our Latest Analysis on GHRS
GH Research Company Profile
GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD).
Featured Articles
- Five stocks we like better than GH Research
- Learn Technical Analysis Skills to Master the Stock Market
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- How to Calculate Return on Investment (ROI)
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- What is Short Interest? How to Use It
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for GH Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GH Research and related companies with MarketBeat.com's FREE daily email newsletter.